Schreiner MediPharm has developed an NFC label for an insulin injection aid from Ypsomed that can be used to automatically identify, authenticate and check the shelf life of a medication.
Diabetes patients who are dependent on insulin for the rest of their lives must administer the vital medication via insulin pumps, syringes or pens. Ypsomed offers the disposable pen for this and other multi-dose therapies. UnoPen with variable dosage adjustment. Schreiner MediPharm has developed an NFC label for this injection aid, which serves as a communication interface between the injector and SmartPilot - an electronic supplement to the pen. The resulting smart device interactively supports patients while they are using the pen and helps them to adhere to their treatment plan.
NFC label designed to fit perfectly
The from Schreiner MediPharm label with an integrated NFC chip has been customised to fit the combination of UnoPen and SmartPilot designed. With the NFC label, the Drug automatically identified, authenticated and checked for shelf life be used. The smart device is used to track the injection date, injection time and delivery quantity and transmit them to the patient's smartphone app via Bluetooth.
The patient is guided interactively through the injection process, supported in real time in the correct use of the pen or informed about discrepancies - for example in the event of deviations from the treatment plan or before an accidental double injection.
Temperature sensor gives warning
Also integrated is a Temperature monitoring that issues a warning, if the pen has been exposed to critical temperatures during use and storage. This is possible thanks to the sensor technology built into the SmartPilot, which digitally networks the UnoPen. The smart device is simply placed on the pen without covering the cap, the mechanism for scaling the dose or the button that triggers the injection. The device remains on the pen during the entire injection process.
Schreiner MediPharm and Ypsomed were already development partners for the SmartPilot application for the YpsoMate autoinjector.
„We have once again decided in favour of a development cooperation with Schreiner MediPharm in order to offer pharmaceutical customers the optimum combination of Connected Device and smart NFC label.“ Andreas Schneider, Innovation & Business Development Director of Ypsomed
The tight radius of the pen and the low tolerances of the attached device were particularly challenging this time. An essential The focus was on machine processing, as the NFC chip integrated into the label must function reliably from production to end use. Schreiner MediPharm uses a special design to ensure this.
SourceSchreiner MediPharm
